The protease medicines company
Learn more
Catalyst Biosciences, Inc. Announces Dismissal of JDS1 Litigation
Catalyst Biosciences Reports Second Quarter 2022 Operating & Financial Results
Catalyst Biosciences Announces Withdrawal of JDS1 Nominations to the Board
More news
